I would urge CMS to scrap this proposal and come to the table with stakeholders and look at other ways that we can address patient medication costs.
Editor's note · Context
Bucshon calls for CMS to reconsider a proposal affecting medication costs.
Share
More from Larry Bucshon
Can we not agree that entities benefiting from the discounts need to show the American people what they are doing with the savings?
one of my legislative priorities is to increase transparency and accountability in the 340B program.
My goal is to ensure that the Office of Attending Physician is one that all Members can respect without concern that its actions or advice are based on anything other than science and reason.
It is clear that the Biden administration has pushed its authorities past reasonable interpretation during the COVID- 19 pandemic. With everything from eviction moratoriums and student loan forgiveness to vaccine and mask mandates being…





